Epstein Secrets

with instructions provided to the General Partner by such Limited Partner) shall cause the Partnership or the General Partner to be in violation of the United States Bank Secrecy Act, the United States Money Laundering Control Act of 1986, the United States International Money Laundering Abatement and Anti-Terrorist

Advisory Committee (or its sub-committees), if formed, shall be to: (i) Be available to confer with the General Partner regarding the progress of Portfolio Investments; (ii) Review and advise the General Partner regarding potential conflicts of interest submitted to them by the General Partner; and (iii) Undert

nt on global health expenditure in 2011. At 10%+' this represents, one of the largest sectors of global GDP. At $2.82 trillion, healthcare spend in Unites States is the largest globally and represents 172% of the US GDP. Moreover, the expenditure on healthcare has grown significantly faster than GDP in 44 of

notice. Proceeds front investments other than short-term investments of cash ("Portfolio Investments") will not be reinvested in new or follow-on Portfolio Investments. The Fund will not borrow or use other recourse leverage in its investment activities, except for short-term borrowings pending receipt of capital

s Shareholders under the CFC rules, and (ii) will be subject to the Section 1248 recharacterization rule described above. In addition, if the Fund is a United States Shareholder of a CFC and a U.S. Partner disposes of its Limited Partner Interest, that Partner generally will recognize income under Section 751 of t

rket at the time of such investment, “toe-hold” investments (e.g. investments that are intended to lead to a potential private or larger investment), Portfolio Investments where the Partnership has the right to designate a director, and follow-on investments in or related to the foregoing; (d) the Fund shall not invest